Brawn Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 5.89 | 2.35 | 3.85 |
| Operating Expense | 5.62 | 2.81 | 4.25 |
| Net Profit | 0.24 | -0.49 | -0.43 |
| Net Profit Margin | 4.07 | -20.85 | -11.17 |
| Earning Per Share | 0.89 | -1.65 | -1.44 |
| EBIDTA | 0.27 | -0.46 | -0.40 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 5.89 |
| Operating Expense | 5.62 |
| Net Profit | 0.24 |
| Net Profit Margin | 4.07 |
| Earning Per Share | 0.89 |
| EBIDTA | 0.27 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 13.46 | 16.49 | 22.23 |
| Operating Expenses Annual | 15.24 | 18.02 | 22.53 |
| Operating Profit Annual | -1.68 | -1.44 | -0.29 |
| Interest Annual | 0.00 | 0.00 | 0.01 |
| Depreciation | 0.11 | 0.10 | 0.11 |
| Net Profit Annual | -1.74 | -1.25 | -0.87 |
| Tax Annual | -0.06 | -0.30 | 0.46 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 13.46 |
| Operating Expenses Annual | 15.24 |
| Operating Profit Annual | -1.68 |
| Interest Annual | 0.00 |
| Depreciation | 0.11 |
| Net Profit Annual | -1.74 |
| Tax Annual | -0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.40 | 0.44 | 0.22 |
| Cash Flow from Operations | 0.05 | -0.03 | 0.32 |
| Cash Flow from Investing | -0.24 | -0.01 | -0.10 |
| Cash Flow from Financing | TBA | TBA | -0.01 |
| Cash Flow at the End | 0.20 | 0.40 | 0.44 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.40 |
| Cash Flow from Operations | 0.05 |
| Cash Flow from Investing | -0.24 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -12.48 | -8.37 | -1.30 |
| PBIT Margin (%) | -13.30 | -8.98 | -1.80 |
| PBT Margin (%) | -13.30 | 141.60 | 178.14 |
| Net PROFIT Margin (%) | -12.93 | -7.58 | -3.91 |
| Return On Networth / Equity (%) | -41.33 | -21.99 | -12.86 |
| Return On Networth /Employed (%) | -18.71 | -20.47 | -5.74 |
| Return On Assets (%) | -18.10 | -17.21 | -12.48 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.40 | 2.27 | 3.19 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -12.48 |
| PBIT Margin (%) | -13.30 |
| PBT Margin (%) | -13.30 |
| Net PROFIT Margin (%) | -12.93 |
| Return On Networth / Equity (%) | -41.33 |
| Return On Networth /Employed (%) | -18.71 |
| Return On Assets (%) | -18.10 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.46 | 0.33 | 0.37 |
| Total Current Assets Annual | 17.50 | 13.14 | 13.40 |
| Non Current Assets Annual | 2.99 | 1.45 | 1.13 |
| Total Shareholders Funds Annual | 3.36 | 5.07 | 6.31 |
| Total Assets Annual | 20.49 | 14.59 | 14.53 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.46 |
| Total Current Assets Annual | 17.50 |
| Non Current Assets Annual | 2.99 |
| Total Shareholders Funds Annual | 3.36 |
| Total Assets Annual | 20.49 |
EPS (INR)
Expected
0.00
Reported
-0.08
Surprise
0.00%
Mar 2023
EPS beaten by 0.00%
Jun 2022
EPS beaten by 0.00%
